CORT - Corcept Therapeutics Incorporated

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue159,20181,32150,286
Cost of Revenue3,5542,0581,361
Gross Profit155,64779,26348,925
Operating Expenses
Research Development40,37623,84415,419
Selling General and Administrative62,41645,24036,949
Non Recurring---
Total Operating Expenses---
Operating Income or Loss52,85510,179-3,443
Income from Continuing Operations
Total Other Income/Expenses Net---
Earnings Before Interest and Taxes52,85510,179-3,443
Interest Expense492,0392,965
Income Before Tax52,8068,140-6,408
Income Tax Expense-76,316--
Minority Interest---
Net Income From Continuing Ops129,1228,140-6,408
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income129,1228,140-6,408
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares129,1228,140-6,408